Biotechnology

AGC Biologics Appoints New Site Head/General Manager of Copenhagen, Denmark Operations

Jeffrey D. Mowery Named Site Head/General Manager BOTHELL, Washington, Oct. 1, 2019 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the appointment ofJeffery D. Mowery as Site Head/General Manager of theCopenhagen,...

2019-10-01 07:00 2290

Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis

* Idiopathic pulmonary fibrosis (IPF) is a severe and fatal disease that causes lung damage and scarring * Blocking a protein called interleukin-11 (IL11), which is abnormally high in the lungs of patients with IPF, can reverse lung fibrosis and scarring in preclinical studies * Enleofen Bi...

2019-09-30 15:00 1062

Preclincal Results of Baoyuan's Next-Generation ROS1/NTRK Inhibitor AB-106 Published in Nature Communications

HANGZHOU, China, Sept. 25, 2019 /PRNewswire/ -- The preclinical results of AB-106 (original code: DS-6051b), an investigational next generation ROS1/NTRK dual inhibitor exclusively in-licensed by AnHeart Therapeutics, a wholly-owned subsidiary of Baoyuan Biopharmaceuticals Technology (Hangzhou) C...

2019-09-25 18:44 4237

AGC Biologics Appoints New Site Head/General Manager of Chiba, Japan Operations

Naofumi Kagami Named Site Head/General Manager  BOTHELL, Washington, Sept. 25, 2019 /PRNewswire/ -- AGC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, announced today the appointment ofNaofumi Kagami as Site Head/General Manager of theChiba, Japan fa...

2019-09-25 01:42 3127

Supply Chain Digitization Creates New Revenue Opportunities in the Vaccine Market

High investment in adult immunization and innovations in DNA vaccines will rejuvenate the vaccines market, finds Frost & Sullivan SANTA CLARA, California, Sept. 24, 2019 /PRNewswire/ -- The need for improved immunogenicity, delivery technologies and reliable supply are driving the shift from the...

2019-09-24 23:28 2200

binx health Announces First Patients Benefiting From Single-Visit Test and Treatment for Chlamydia and Gonorrhea

binx FDA-cleared platform already impacting human health-poised to transform care for millions BOSTON, Sept. 23, 2019 /PRNewswire/ -- binx health, the pioneer in anywhere, anytime testing for women's health, today announced the first real-world use of the binxio platform, delivering same-visit d...

2019-09-23 20:30 2898

2019 CSCO| CStone announces promising ORR, anti-tumor activity and safety data with its anti-PD-L1 antibody CS1001 in MSI-H/dMMR solid tumors

SUZHOU, China, Sept. 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced results from the microsatellite instability high/deficient mismatch repair (MSI-H/dMMR) solid tumor cohort in the GEMSTONE-101 Phase Ib study of the Company's investigation...

2019-09-22 14:22 1907

2019 CSCO | CStone announces preliminary results from Phase I trial of CS1002 demonstrating characteristics comparable to ipilimumab

SUZHOU, China, Sept. 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced preliminary results from the Phase Ia trial of the Company's anti-CTLA-4 antibody in an oral presentation at the 22nd Annual Meeting of the Chinese Society of Clinical Onco...

2019-09-22 13:39 2072

Global Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 5, 2019

HONG KONG, Sept. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its 20...

2019-09-20 19:00 12592

Advanced Aesthetic Technologies and China National Biotec Group Announce Strategic Cooperation

BROOKLINE, Massachusetts, Sept. 19, 2019 /PRNewswire/ -- Advanced Aesthetic Technologies, Inc. (AAT), a leader in aesthetic gel implant technology, and China National Biotec Group (CNBG), a subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM) today announced the execution of ...

2019-09-19 23:12 3413
1 ... 171172173174175